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ABSTRACT: Three new and seven known calopins were isolated from Caloboletus 
radicans. The structures of the new cyclocalopins, 8-deacetylcyclocalopin B (1), 
cyclocalopin A-15-ol (2), and 12,15-dimethoxycyclocalopin A (3), were mainly elucidated by 
NMR and MS data analysis. The stereochemistry of 1–3 was assigned based on ROE 
correlations, coupling constants and by comparison of their CD spectra with those of similar 
known calopins. While 1–10 were inactive against two cancer cell lines, they displayed 
antistaphylococcal activity against methicillin-resistant Staphylococcus aureus strains 
(MRSA) with MIC values of 16−256 μg/mL. Moreover, some calopins were active against 
the fish pathogen Enterococcus faecalis F1B1. 
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Antibiotic resistance is one of the major challenges of today’s global public health. 
Bacteria resistant to antibiotics are described as “nightmare bacteria” by the World health 
leaders that “pose a catastrophic threat” to people in every country in the World.1 Among the 
antibiotic resistant pathogens, methicillin-resistant strains of Staphylococcus aureus (MRSA) 
are spreading worldwide within hospitals, extended care facilities and the community at 
large. Examples of infections caused by MRSA include respiratory, skin, soft tissue, bone, 
joints and urinary tract infections, endocarditis, acute osteomyelitis, meningitis, neonatal liver 
abscesses, epidural abscesses, mastitis, toxic shock syndrome, and even chorioamnionitis.2 
According to a recent report, more than 25% of S. aureus infections in Europe are caused by 
MRSA.3 MRSA is contagious and can be spread through direct or indirect contact with an 
infected person. The treatment of these infections is expensive, problematic and time 
consuming. Moreover, long-term antibiotic medication to treat bacterial infections causes 
numerous side effects.4 These facts indicate the urgency to discover sufficiently active new 
natural scaffolds for the development of antibiotics with less or no side effects. It is well 
known that nature produces an amazing variety and number of compounds, which are both a 
fundamental source of new chemical diversity and an integral component of today’s 
pharmaceutical compendium.5-7 However, readily available sources of natural products are 
often well investigated. Therefore, our search for new bioactive natural products is focused 
on mushrooms which are not easily accessible, since they usually cannot be cultivated and 
only occur temporarily in their natural environment.8,9 This also applies to Caloboletus 
radicans (Pers.) Vizzini, (= Boletus radicans Pers.: Fr., German name: Wurzelnder 
Bitterröhrling). The German name of this species reveals that the fruiting bodies taste bitter 
and are consequently inedible. Several years ago the bitter taste of the fruiting bodies was 
attributed to the presence of the previously unknown calopins.10-12 Although even total 
syntheses of several calopins have been published,13-15 there are no reports on the bioactivity 
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of the calopins. The free radical-scavenging activity against DPPH,16,17 superoxides,17 and 
PABS17 radicals has been reported. 
In this manuscript, we describe the isolation and structure elucidation of new (1–3) and 
previously reported calopins (4–10) from fruiting bodies of C. radicans which turned out to 
exhibit anti-staphylococcal activity and activity against fish-pathogenic bacteria. 
Fractionation of the MeOHH2O extract from freeze-dried defatted fruiting bodies of C. 
radicans by first partitioning with n-hexane and EtOAc, followed by repeated reversed-phase 
HPLC of the EtOAc soluble material with a subsequent MeCNH2O gradient and 
MeOHH2O isocratic eluents yielded three new cyclocalopin derivatives 1–3 and seven 
previously known calopins 4–10.  
The known calopins were identified as cyclopinol (4), cyclocalopin B (5), cyclocalopin A 
(6), 15-methoxycyclocalopin A (7), cyclocalopin E (8), calopin (9) and O-acetylcalopin (10) 
by comparison of their 1H NMR, 13C NMR, ESIMS and CD data to those reported 
previously.10-12 
The molecular formula C17H24O7 of 1 was deduced by high-resolution ESIMS of the 
pseudomolecular ion. Seventeen carbon resonances were observed in the 13C NMR spectrum 
which were assigned with the help of the HSQC spectrum to one ester carbonyl group at δC 
173.9 ppm, one acetyl carbon at δC 176.0 ppm, two sp2 carbons at δC 133.3 and 123.1 ppm, 
two oxygenated methane carbons at δC 71.9 and 77.5 ppm, one oxygenated carbon with 
acetyl group at δC 73.5 ppm, one oxygenated methylene carbon at δC 72.9 ppm, one 
oxygenated quaternary carbon at δC 108.3 ppm, one methylene carbon at δC 27.2 ppm, two 
methine carbons at δC 30.3 and 47.1 ppm, one quaternary carbon at δC 52.9 ppm and four 
methyl carbons at δC 14.6, 17.5, 19.5 and 21.1 ppm. Based on these observations, the planar 
structure of 1 was established with the help of COSY, HMBC and ROESY correlations 
(Figure 1). A comparison of the NMR data of 1 with those of the known compound 5 
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revealed that 1 is structurally closely related to 5.10 The new calopin (1) differs from 
compound 5 by the absence of one of the two acetyl groups of 5. The acetyl group of 1 was 
shown to be attached to C-7 by an HMBC correlation of H-7 at δH 5.07 ppm to the acetyl 
carbon at δC 173.9 ppm (Figure 1). The coupling constants in the 1H NMR and the CD data of 
510 are similar to those of 1. Furthermore, the NOE correlations (Figure 1) of H-3 with H-8, 
of H-7 with H-13, and of H-11 with H-14 in the NOESY spectrum of 1 indicate that 8-
deacetylcyclocalopin B (1) has the same configuration as cyclocalopin B (5). 
The molecular formula of 2 was determined to be C15H20O7 by high-resolution ESIMS of 
the pseudomolecular ion. The 1H and 13C NMR data (Table 1) in combination with the 
molecular formula indicated that 2 is structurally closely related to cyclocalopin A (6).10 
Instead of the methyl group present in 6, 2 bears a CH2OH group at C-9. The position of the 
CH2OH group at C-9 was deduced from the HMBC correlations of H-10 at δH 6.96 ppm with 
the methylene carbon C-15 at δC 60.2 ppm, and of H-15 at δH 4.30 ppm with the carbonyl 
carbon C-8 at δC 199.3 ppm (Figure 1). Due to the observed NOE correlations (Table 1), 
nearly identical coupling constants, and CD spectra cyclocalopin A-15-ol (2) possesses the 
same configuration as 6. 
The molecular formula C17H24O7 of 3 was derived from the pseudomolecular ion in the 
high-resolution ESIMS in combination with 1H and 13C NMR data. The 1H and 13C NMR 
data (Table 1) of 3 are very similar to those of 15-methoxycyclocalopin A (7).12 Compound 3 
differs from 7 only in respect of the presence of two broad singlets at δH 3.17 and 3.36 ppm 
instead of one, revealing that 3 possesses two methoxy groups. One CH3O- group is attached 
at C-12 due to HMBC correlations of H-17 at δH 3.17 ppm with the anomeric carbon C-12 at 
δC 110.9 ppm and with the carbon C-6 at δC 56.7 ppm (Figure 1). The second CH3O- group is 
located at C-15 as shown by the HMBC correlation of H-16 at δH 3.36 ppm with the 
methylene carbon C-15 at δC 68.6 ppm. The stereochemistry of 12,15-dimethoxycyclocalopin 
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A (3) was assigned to be the same as that of 7 because of nearly identical coupling constants 
and CD data. 
Calopins 110 (100 µM) were inactive against PC3, prostate cancer and HepG2, liver 
hepatoblastoma cells. The activity of 110 against a panel of S. aureus strains, including the 
multidrug resistant (MDR) and methicillin-resistant Staphylococcus aureus (MRSA) strain 
SA-1199B that overproduces the NorA efflux pump and possesses a high level of resistance 
to some fluoroquinolones,18,19 the macrolide-resistant strain RN4220,20 the MRSA strain 
XU212 that is resistant to tetracycline,21 the standard laboratory strain ATCC 25923,21 and the 
epidemic methicillin-resistant strain EMRSA-15 was evaluated.19 Calopins 110 displayed 
activity against SA-1199B but turned out to be inactive against the strain RN4220 (Table 2). 
Moreover, 1 was found to be more active than the positive control norfloxacin.19-22 against 
ATCC 25923 and SA-1199B with MICs of 16 µg/mL. In general, compound 3 was found less 
active than the calopins 1 and 2. The reason might be the lack of a free hydroxy group at C-
12. 
Compounds 3, 5, 6, 9 and 10 were also tested against the phytopathogens Phytophthora 
capsici, a pathogen of several plants including peppers,23 Colletotrichum gloeosporioides 
strain CG12, a phytopathogen of strawberry,24 Magnaporthe oryzae Triticum pathotype strain 
JP4,25 a wheat blast fungus, and against the two fish pathogenic Enterococcus faecalis 
strains26 FF11 and F1B1. The tested compounds displayed varying levels of inhibitory effects 
against the strain F1B1 at 40 µg/disk but were inactive against C. gloeosporioides, M. oryzae 
Triticum pathotype and E. faecalis strain FF11 up to 1000 µg/ml. The inhibition zones around 
the disks were recorded to be 5.5 ± 0.9 for compound 3, 5.5 ± 1.0 for 5, 7.1 ± 1.5 for 6, 5.6 ± 
1.3 for 9, and 9.5 ± 1.2 mm for compound 10. Since the fish pathogenic E. faecalis strain 
F1B1 is highly resistant to several antibiotics such as amoxicillin, ampicillin, cefradine, 
cefuroxime, erythromycin and penicillin G,26 the calopins might be useful as lead structures 
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for the development of agents for the control of fish pathogens.  
 
EXPERIMENTAL SECTION 
General Experimental Procedures. Extraction was performed in a 5 L Erlenmeyer flask 
with constant stirring using an IKA magnetic stirrer. Filtration was carried out with filter 
paper with a particle retention size of 1215 μm. Organic solvents were evaporated under 
reduced pressure using a rotary evaporator (IKA) at room temperature (26 °C). A benchtop 
manifold freeze-drier from Christ was used to obtain completely H2O free samples. Semi-
preparative HPLC separation was performed on an HPLC system equipped with two Waters 
590EF pumps, the automated gradient controller 680 and a Knauer UV/vis detector. Extracts 
from C. calopus were separated first on a C18 ec column (Nucleodur, 16 × 250 mm, 5 μm, 
100 Å, Macherey-Nagel) with the following gradient: Starting from MeCNH2O (+0.1% 
HOAc) (10:90) linear to MeCNH2O (+0.1% HOAc) (40:60) within 30 min, then within 20 
min to 100% MeCN; flow rate 6 mL/min; UV detection at 250 nm. A second separation step 
was performed on a C18 ec column with a smaller diameter (Nucleodur, 10 × 250 mm, 5 μm, 
100 Å, Macherey-Nagel) with the following isocratic separation program: MeOHH2O 
(20:80); flow rate 3 mL/min; UV detection at 250 nm. Optical rotations: Perkin-Elmer 243. 
CD: Applied Photophysics ChirascanTM CD spectrometer (1 mm cell). NMR: Bruker Avance 
DRX-600 (1H NMR at 600.22 MHz, 13C NMR at 150.91 MHz, 300 K), and Bruker Avance 
WB-360 (1H NMR at 360 MHz, 13C NMR at 91 MHz, 300 K); chemical shifts in ppm are 
referenced to the residual solvent signal (D2O: δH = 4.79 ppm; CDCl3: δH = 7.26 ppm, δC = 
77.0 ppm). LC-ESIMS spectra were obtained on an LCQ DecaXP Plus ESIMS spectrometer 
(Thermo Fisher Scientific Inc., USA). The spectrometer was operated in the positive mode 
(0.625 spectra s−1; mass range 50−1000). Nitrogen was used as sheath gas (80 arbitrary units) 
and helium served as collision gas. The spectrometer was equipped with a Hewlett-Packard 
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HPLC system (Series 1100) consisting of a degasser, a pump system, a DAD detector, and an 
auto-sampler (injection volume 10 μL). The separations were performed with a C18 ec column 
(Nucleodur, 4.6 × 250 mm, 5 μm, 100 Å, Macherey-Nagel) using the following gradient 
program: Within the first 50 min linear from MeCNH2O (+0.1% HOAc) (10:90) to 100% 
MeOH, flow rate 0.66 mL/min. HR-ESIMS spectra of compounds 1 and 2 were recorded on 
a Finnigan MAT 95 high resolution, double focusing magnetic sector field mass spectrometer. 
Accurate mass measurements were achieved using the accelerating voltage of 5 kV, 
taurocholic acid as an internal standard, ([MH] = 514.2839), a resolution between 5000 and 
10000, and a scan range of 150 to 1000 m/z. The HR-ESIMS spectrum of compound 3 was 
acquired with a Q Exactive Plus mass spectrometer (Thermo Fisher Scientific, Bremen, 
Germany), using a heated electrospray ionization (HESI-II) source in positive mode at a 
flow-rate of 5 µL per minute. MS measurement was performed in full MS mode with a 
resolution of 280,000, a scan range of 150 to 800 m/z using a spray voltage of 3 kV.  
Collection of Mushrooms. Fruiting bodies of C. radicans Pers.: Fr. (leg. et det. N. 
Arnold) were collected in September and October 1998 at Gerolfing in Bavaria, Germany and 
immediately frozen and stored at −20 °C. Voucher samples of C. radicans are deposited at the 
Institut für Organische und Analytische Chemie, Universität Bremen, Germany. 
Extraction and Isolation. Frozen fruiting bodies of C. radicans (2.0 kg) were crushed 
and extracted with 2 L of MeOH−H2O (1:1 v/v) (two times) with constant stirring at 200 rpm 
and 25 °C for 1 h. The supernatant was filtered, solvent was evaporated, residue re-dissolved 
in MeOH−H2O (1:4 v/v) and partitioned between n-hexane and EtOAc. The solvents from n-
hexane (Hx), EtOAc and MeOH−H2O (MH) fractions were evaporated and subjected to an 
LC-MS and 1H NMR analysis. The LC-MS and 1H NMR data of the Hx and MH fractions 
clearly indicated the presence of fat and sugar, respectively, whereas the EtOAc fraction 
contained several classes of compounds including nucleosides. The EtOAc fraction (455.6 
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mg) was subjected to further purification. The EtOAc fraction was dissolved in methanol and 
filtered with a C18 ec cartridge. The supernatant was separated by HPLC first on an C18 ec 
column with 16 mm diameter, on an C18 ec column with 10 mm diameter. A 2 kg amount of 
fruiting bodies yielded 2.8 mg of 8-deacetylcyclocalopin B (1), 2.3 mg of cyclocalopin A-15-
ol (2), 5.3 mg 12,15-dimethoxycyclocalopin A (3), 2.5 mg of 4, 8.2 mg of 5, 12.5 mg of 6, 
3.5 mg of 7, 1.8 mg of 8, 15.5 mg of 9 and 22.8 mg of 10. 
8-Deacetylcyclocalopin B (1): colorless oil; HPLCprep, tR 23.8 min (step 1), 30.5 min (step 2); 
LC-(+)-ESIMS tR 24.5 min; [α]24D −0.21 (c 0.003, MeOH); UV/Vis (MeOH) λmax 256, 268, 
274 nm; CD (CH3CN) λmax (Δε) 221 (+0.77), 231 (+0.38), 239 (0), 251 (−0.19), 271 (−0.05) 
nm; 1H and 13C NMR (see Table 1); HR-(+)-ESIMS m/z 363.1409 [M + Na]+ (calcd for 
C17H24O7Na+, 363.1419 [M + Na]+). 
Cyclocalopin A-15-ol (2): amorphous solid, HPLCprep, tR 30.6 min (step 1), 35.5 min (step 2); 
LC-(+)-ESIMS tR 30.9 min; [α]24D −46.5 (c 0.05, CHCl3); CD (MeOH) λmax (Δε) 214 (+3.69), 
223 (+1.55), 228 (0), 243 (−3.20), 253 (−2.01), 323 (+0.87) nm; 1H and 13C NMR (see Table 
1); HR-(−)-ESIMS m/z 311.1135 [M − H]− (calcd for C15H19O7, 311.1131 [M − H]−). 
12,15-Dimethoxycyclocalopin A (3): amorphous solid, HPLCprep tR 20.52 min (step 1), 22.30 
min (step 2); LC-(+)-ESIMS tR 22.85 min; [α]24D +35.5 (c 0.01, CHCl3); CD (MeOH) λmax 
(Δε) 216 (+4.95), 220 (+0.55), 228 (0), 243 (−4.20), 323 (+0.87) nm; 1H and 13C NMR (see 
Table 1); HR-(+)-ESIMS m/z 363.1409 [M + Na]+ (calcd for C17H24O7Na+, 363.1419 [M + 
Na]+). 
Test for Anti-Staphylococcal Activity. The anti-MRSA activity of the compounds 1−10 was 
investigated with the standard MRSA strains ATCC 25923, XU212, SA-1199B, RN4220, and 
EMRSA-15 by a broth dilution assay.27 All five MRSA strains were incubated separately for 
24 h at 37 oC on nutrient agar (Oxoid) and prepared for an inoculum density of 5×105 colony 
forming units in normal saline water (9 g/L) by comparison with a 0.5 MacFarland turbidity 
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standard. To avoid contamination, sterilized nutrient agar, saline water and Mueller-Hinton 
broth (MHB; Oxide) were used. The positive control (norfloxacin) was prepared by 
dissolving the antibiotic in DMSO (Sigma). After having all these requisites in hand, MHB 
was dispensed into 10 wells of a 96 well microtiter plate (Nunc, 0.3 ml volume per well). The 
compounds 1−10 and antibiotic were serially diluted (over the range of concentrations 
0.5−256 μg/mL) into each of the wells followed by the addition of the bacterial inoculum, 
and the microtiter plate was incubated at 37 °C for 18 h. A DMSO control was included in all 
assays. The MIC recorded the lowest concentration at which no growth was observed. This 
was facilitated by the addition of 20 μL of a 5 mg/mL methanolic solution of 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT; Sigma) to each of the wells 
and incubation for 20 minutes. Bacterial growth was indicated by a color change from yellow 
to dark blue. All MICs were determined independently at least three times.  
Activity against Oomycetes and Fungi by a Disk Diffusion Method.28 To test the 
inhibitory activity of the compounds 3, 5, 6, 9 and 10, the oomycete Phytophthora capsici 
and the fungi Colletotrichum gloeosporioides and Magnaporthe oryzae triticum Pathotype 
were cultured on 10% V8 agar medium at 25 °C in the dark.29 A 4 mm diameter mycelia agar 
block was placed at the center of the PDA plate (9 cm). The compounds were dissolved in 
acetone and a stock solution of 1000 µg/mL was prepared. A 40 µL sample of each stock 
solution was carefully applied onto a paper disk (8 mm) and allowed to dry. After evaporation 
of the solvent, the disk was placed 4 mm apart from the mycelia block of the pathogen and 
incubated at 25 °C in the dark for 5 days. Then, the zone of inhibition was measured (mm) for 
each sample against control strains. Each treatment was replicated three times.  
Inhibitory Activity against Fish Pathogens by a Disk Diffusion Method.28 To test the 
antibacterial activity of compounds 3, 5, 6, 9 and 10 against Enterococcus faecalis strains 
FF11 and F1B1, bacterial suspensions (1 × 105 CFU/mL) were spread on the agar plate. A 40 
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µL sample of each compound (concentration 1000 µg/mL) in acetone was carefully applied 
onto a paper disk (8 mm) and allowed to dry the solvent and then placed onto the MH agar 
plate. The inhibitory activity of the compound is displayed as bacteria free halo zone after 2 
days of incubation at 37 °C. The diameter of the halo zone was measured and the result was 
expressed as mean value ± standard error of three replications of each dose of each 
compound. Antibiotic azithromycin was used as positive control. 
Cytotoxicity Test (SRB Assay). The cancer cell growth inhibitory activity of the compounds 
1−10 was evaluated by a sulforhodamine B (SRB) assay.30,31 In brief, prostate cancer (PC3) 
and liver hepatoblastoma (HepG2) cells were cultured in Dulbecco's Modified Eagle's 
Medium (DMEM) media supplemented with 10% fetal bovine serum and 1% penicillin-
streptomycin (USA) and maintained at 37 °C in a humidified incubator with an atmosphere 
of 5% CO2. The cells were seeded in 96-well microtiter plates in 100 µl culture medium at 
cell concentration of 5 × 104 cells/mL. After an overnight adaptation period, the cells were 
treated with test compounds 1−10 in a CO2 incubator for 72 h. When cells reached 70% 
confluence in a microtiter plate, the medium was replaced with DMEM 5% FBS and 
incubated further 48 h. Then, the medium was discarded, and cells were fixed by adding 50 
μL of 10% trichloroacetic acid (TCA, Sigma-Aldrich Chemical, St. Louis, MO, USA). The 
cells were then incubated at 4 °C for 30 min; TCA was drained off, and the plates were left to 
dry. Then, 50 μL of SRB stain (10 mg of 1% acetic acid, Sigma) were added to each well for 
30 min. Finally, the plates were washed four times with 1% acetic acid (100 μL). The OD was 
measured at 540 nm using an ELISA reader (Bio-Rad). Paclitaxel was used as a positive 
control, whereas cells incubated only with 0.05% of DMSO were used as a negative control. 
All experiments were performed in triplicate. 
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Figure 1. COSY, key HMBC, and key NOE correlations for 13. 
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Table 1. 1H NMR (600.22 MHz, 300 K) and 13C NMR (151.91 MHz, 300 K) Data and ROESY Correlations for Compounds 13. 
 
 
  a8-deacetylcyclocalopin B (1) bcyclocalopin A-15-ol (2) a12,15-dimethoxycyclocalopin A (3) 
no. δC, type δH (J in Hz) NOESY δC, type δH (J in Hz) aROESY δC, type δH (J in Hz) ROESY 
1 176.0, C   173.2, C   174.6, C   
2 73.5, CH 4.89 (d, 10.5) 3, 5, 17 73.8, CH 4.56, (d, 10.0)  3, 5 73.3, CH 4.74 (d, 10.3) 3, 5 
3 47.1, CH 2.77 (dd, 10.5, 
10.5) 
2, 5, 8, 14 46.6, CH 2.19 (dd, 10.0, 
10.0) 
2, 5 ,14 45.4, CH 2.24 (dd, 10.3, 
10.3) 
2, 5, 14 
4 30.3, CH 2.23 (m) 5, 14 30.8, CH 2.21 (m) 5, 11, 14 29.6, CH 2.21 (m) 5, 11, 14 
5 
 
5 
72.9, CH2 4.05 (dd, 11.0, 
11.0) 
4.21 (m) 
3, 5, 14 
 
4, 5, 14 
72.5, CH2 3.82 (dd, 11.0, 
11.0) 
4.07 (dd, 11.0, 
1.6) 
2, 3, 5, 14 
 
4, 5, 14 
72.6, CH2 4.00 (dd, 11.2, 
11.2) 
4.18 (dd, 11.2, 
3.2) 
2, 3, 5, 14 
 
4, 5, 14 
6 52.9, C   56.5, C   56.7, C   
7 77.5, CH 5.07 (d, 9.4) 8, 11, 13 76.3, CH 4.29 (s) 11, 13 76.2, CH 4.63 (s) 11, 13 
8 71.9, CH 4.22 (d, 9.4) 3, 7, 15 199.3, C   200.4, C   
9 133.3, C   136.1, C   132.4, C   
10 123.1, CH 5.58 (m) 11, 11, 14, 15 145.9, CH 6.96 (m) 11, 11, 15 150.6, CH 7.18 (m) 11, 11, 15, 
15 
11 
 
11 
27.2, CH2 2.32 (dm, 20.2) 
 
2.18 (dm, 20.2)  
10, 11, 14 
 
7, 10, 11, 13 
28.0, CH2 2.78 (dd, 21.3, 
5.3) 
2.55 (dm, 21.3)  
4, 10, 11, (14) 
 
7, 10, 11, 13 
27.8, CH2 2.85 (dd, 21.1, 
6.2)  
2.69 (dm, 21.1)  
4, 10, 11, 14 
 
7, 10, 11, 13  
12 108.3, C   107.6, C   110.9, C   
13 19.5, CH3 1.45 (s) 7, 11, 15 21.6, CH3 1.61 (s) 7, 11 13.9, CH3 1.55 (s) 7, 11, 17 
14 14.6, CH3 0.92 (d, 6.5) 3, 4, 5, 5, 10, 
11 
16.8, CH3 0.77 (d, 6.0) 3, 4, 5, 5, 
(11) 
15.5, CH3 0.77 (d, 6.5) 3, 4, 5, 5, 
(11)  
15 17.5, CH3 1.74 (s) 8, 10 60.2, CH2 4.30 (m) 10 68.6, CH2 4.08 (d, 12.3) 
4.24 (d, 12.3) 
10, 15, 16 
10, 15, 16 
16 173.9, C      57.7, OCH3 3.36 (s) 15, 15 
17 21.1, CH3 2.14 (s) 2    48.4, OCH3 3.17 (s) 13 
Chemical shifts and coupling constants of 13 were determined in aD2O and bCDCl3+CD3OD (10:1), respectively. Assignments were based on 2D NMR including HSQC 
and HMBC. Coupling constants were measured using 1H NMR in combination with phase-sensitive COSY correlations. Well-resolved couplings are expressed with 
coupling patterns and coupling constants in Hertz (Hz) in parentheses. 
Table 2. Anti-Staphylococcal Activity of the Compounds 1–10. 
 
 
Compound Microorganism, MIC [µg/mL] 
 ATCC 
25923 
XU212 SA-1199B RN4220 EMRSA-15 
1 16 32 16 ND 32 
2 64 64 128 ND 128 
3 128 128 256 ND 256 
4 32 ND 64 ND 64 
5 ND 64 64 ND ND 
6 32 ND 64 ND 64 
7 64 128 64 ND 128 
8 64 64 128 ND 64 
9 64 128 128 ND 128 
10 ND 64 128 ND 64 
p. c. 32 32 64 ND 32 
p. c. = Positive control (Norfloxacin). ND = Not detectable. 
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